Safety Review Committees (SRCs) and Data Monitoring Committees (DMCs) make critical decisions based on increasingly complex clinical trial data. Yet many review processes still depend on static reports that make it difficult to investigate emerging safety signals, answer questions during meetings, and understand the clinical context behind a finding.
In this webinar, experts from MMS will explore how interactive safety visualizations can help SRCs and DMCs move beyond traditional review workflows. The session will show how reviewers can move directly from a potential signal to the underlying participant-level data, investigate questions during live discussions, and gain a clearer view of emerging safety trends.
The speakers will demonstrate how Datacise®, MMS’s interactive clinical data review platform, can bring laboratory findings, adverse events, dosing information, concomitant medications, and participant-level trends together in one environment. They will also discuss how interactive review can reduce follow-up requests, improve traceability, support reviewer independence, and enable more timely safety decisions.
Led by:
Chris Schoonmaker, Chief Operating Officer
Andrew Mills, Strategic Principal Statistician
Kris Wenzel, Director, Data Science
Watch This Webinar To:
- Understand how interactive safety visualizations can support faster, more informed SRC and DMC decision-making
- Learn how integrated clinical data can help reviewers assess laboratory findings, adverse events, dosing, concomitant medications, and participant-level trends in context
- Identify best practices for improving traceability, reducing follow-up requests, and moving beyond static safety review workflows
What You Will Learn:
- Why static outputs can limit effective safety review and delay decision-making
- How interactive visualizations can help committees investigate emerging safety signals in real time
- How integrated clinical data can provide the context needed to evaluate laboratory findings, adverse events, dosing, and concomitant medications
- How interactive workflows can reduce additional analysis requests and follow-up meetings
- How Datacise® supports efficient, traceable, and informed SRC and DMC decision-making
Who will benefit from attending?
-
This webinar is intended for:
-
Clinical operations professionals
-
Statisticians
-
Biometrics leaders
-
Chief medical officers
-
Others involved in clinical trial safety oversight and review.
-
FAQs
Who is this webinar for?
This webinar is designed for clinical operations professionals, statisticians, biometrics leaders, chief medical officers, safety review committee members, data monitoring committee members, and others involved in clinical trial safety oversight and review.
Will there be a recording available?
Yes, a recording will be shared with all registered attendees after the live session.
Where can I get more information on the content presented?
To connect with the presenters or learn more about the topics discussed, please email info@mmsholdings.com and our team will direct your inquiry to the appropriate expert.